Enliven Therapeutics Director Sold Shares Worth Over $606K
Alpha Vantage · TradingView · · AI-summarised by FinFlash
A director at Enliven Therapeutics, Garland J. Scott, reported selling 13,000 shares of common stock for a total of $606,719. The shares were sold on 2026-10-01 at an average price of $46.6707 per share, and following this transaction, the reporting person no longer directly owns common stock in the company.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.